On April 8, 2022, Kaleido announced that the Board of Directors voted to immediately wind-down and cease all of the Company’s ongoing operations and terminate all the company’s employees. While this is a difficult next step for the company, we believe in the foundational science and are working hard to find future pathways for our employees.

We delivered formal notice to The Nasdaq Stock Market, Inc. that we intend to voluntarily delist our Common Stock from the Nasdaq Global Select Stock Market in connection with cessation of all of our operations on April 8, 2022.  We plan to file a Form 25 with the Securities and Exchange Commission on or about April 18, 2022 to effect the voluntary delisting of the Common Stock under Section 12(b) of the Securities Exchange Act of 1934, as amended.